Madrigal Pharmaceuticals, Inc. Stock Deutsche Boerse AG
Stocks
YDO1
US5588681057
Biotechnology & Medical Research
|
Real-time Estimate
Tradegate
05:53:40 02/10/26 am AEST
|
5-day change | 1st Jan Change | ||
| 447.55 EUR | +0.73% |
|
-1.09% | -10.14% |
| 24/09 | Analyst recommendations: Dropbox, Etsy, Meta Platforms, Okta, Rollins… |  |
| 23/09 | Citigroup Initiates Madrigal Pharmaceuticals at Buy With $725 Price Target | MT |
| Market Cap | 11.64B 10.34B 9.67B 8.81B 16.59B 1,121B 16.82B 117B 45.29B 571B 43.72B 42.77B 1,834B | P/E 2026 * |
-80.1x | P/E 2027 * | 92.9x |
|---|---|---|---|---|---|
| Enterprise Value | 11.12B 9.88B 9.24B 8.42B 15.84B 1,071B 16.06B 112B 43.25B 545B 41.75B 40.84B 1,751B | EV / Sales 2026 * |
7.28x | EV / Sales 2027 * | 5.03x |
| Free-Float |
94.17% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| MDGL | Delayed | |
CBOE
| MDGL | Real-time | |
|
Tradegate
| YDO1 | Real-time | |
|
Deutsche Boerse AG
| YDO1 | Delayed | |
|
Börse Stuttgart
| YDO1 | Delayed | |
|
Boerse Muenchen
| YDO1 | Real-time | |
|
Borsa Italiana
| 1MDGL | End-of-day quote | |
|
Xetra
| YDO1 | Delayed |
Last Transcript: Madrigal Pharmaceuticals, Inc.
| 1 day | +0.72% | ||
| 1 week | -1.09% | ||
| Current month | +0.16% | ||
| 1 month | -3.62% | ||
| 3 months | -1.55% | ||
| 6 months | -2.07% | ||
| Current year | -10.14% |
| 1 week | 442.1 |  | 456.4 |
| 1 month | 442.1 | | 471.9 |
| Current year | 354 | | 506.4 |
| 1 year | 347.5 | | 523.2 |
| 3 years | 112.6 | | 523.2 |
| 5 years | 47 | | 523.2 |
| 10 years | 11.31 | | 523.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
William Sibold
CEO | Chief Executive Officer | 59 | 08/09/2023 |
Mardi Dier
DFI | Director of Finance/CFO | 62 | 11/03/2024 |
David Soergel
CTO | Chief Tech/Sci/R&D Officer | 58 | 21/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Rebecca Taub
BRD | Director/Board Member | 74 | 01/07/2016 |
Richard Levy
BRD | Director/Board Member | 68 | 11/08/2016 |
James Daly
BRD | Director/Board Member | 64 | 27/06/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.73% | -1.09% | - | - | 11.64B | |
| +4.16% | -0.36% | +49.37% | +94.17% | 74.46B | |
| -0.61% | +0.69% | +36.36% | +82.72% | 60.14B | |
| -2.54% | -1.65% | +4.86% | +33.32% | 48.15B | |
| -3.10% | -4.95% | +28.28% | +34.84% | 44.25B | |
| +0.60% | +3.59% | +351.46% | +691.13% | 43.99B | |
| -2.01% | -0.15% | +7.24% | +101.37% | 41.61B | |
| +3.32% | +3.49% | +11.18% | +51.23% | 29.97B | |
| +4.77% | +6.16% | +36.77% | +22.78% | 29.31B | |
| -4.42% | -9.59% | -25.38% | +333.17% | 24.93B | |
| Average | +0.10% | +1.97% | +55.57% | +160.53% | 44.09B | |
| Weighted average by Cap. | +0.24% | +1.83% | +60.21% | +151.87% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.53B 1.36B 1.27B 1.16B 2.18B 147B 2.21B 15.35B 5.94B 74.9B 5.73B 5.61B 241B | 2.13B 1.89B 1.77B 1.61B 3.03B 205B 3.07B 21.39B 8.28B 104B 7.99B 7.82B 335B |
| Net income | -183M -163M -152M -139M -261M -17.62B -264M -1.84B -712M -8.97B -687M -672M -28.82B | 179M 159M 149M 135M 255M 17.23B 258M 1.8B 696M 8.77B 672M 657M 28.18B |
| Net Debt | -525M -466M -436M -397M -747M -50.5B -758M -5.27B -2.04B -25.72B -1.97B -1.93B -82.61B | -943M -838M -783M -714M -1.34B -90.81B -1.36B -9.48B -3.67B -46.25B -3.54B -3.46B -149B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/10/26 | EUR 445.00 | +0.16% | 0 |
| 30/09/26 | EUR 444.30 | -0.22% | 0 |
| 29/09/26 | EUR 445.30 | -1.68% | 5 |
| 28/09/26 | EUR 452.90 | +0.53% | 0 |
| 25/09/26 | EUR 450.50 | +0.13% | 3 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MDGL Stock
- YDO1 Stock
Select your edition
All financial news and data tailored to specific country editions
